G7NKM4 (G7NKM4_MACMU) Macaca mulatta (Rhesus macaque)
Peptidyl-prolyl cis-trans isomerase UniProtKBAFDB90v4InterProInteractive Modelling
165 aa; Sequence (Fasta) ;
39 identical sequences
It is possible new templates exist for this target since these models were created.
Available Structures
177 Experimental Structures
Description | PDB ID | Oligo-state | Range | Ligands | ||
---|---|---|---|---|---|---|
Structure of PPIA in complex with FP29092, a Helicon Polypeptide |
Heteromer P62937; | 1×EDO; 1×NH2; 1×WHL; | ||||
Assess | ||||||
Tricomplex of RMC-7977, KRAS G12C, and CypA |
Heteromer P01116; P62937; | 1×GNP; 1×MG; 1×ZNI; | ||||
Assess | ||||||
Tricomplex of RMC-4998, KRAS G12C, and CypA |
Heteromer P01116; P62937; | 1×GNP; 1×MG; 1×CL; 1×YV2; | ||||
Assess | ||||||
Tricomplex of RMC-7977, NRAS WT, and CypA |
Heteromer P01111; P62937; | 1×GNP; 1×MG; 1×ZNI; | ||||
Assess | ||||||
X-ray crystal structure of Cyclophilin A/HIV-1 CA N-terminal domain (1-146) M-type H87A,A88M,G89A C… |
Heteromer P62937; Q72497; | |||||
Assess | ||||||
X-ray crystal structure of Cyclophilin A/HIV-1 CA N-terminal domain (1-146) M-type H87A,A88M Comple… |
Heteromer P62937; Q72497; | |||||
Assess | ||||||
Cyclophilin A complexed with a fragment of HIV-1 GAG protein |
Heteromer P05889; P62937; | |||||
Assess | ||||||
Complex of Rabbit Endogenous Lentivirus (RELIK)Capsid with Cyclophilin A |
Heteromer P62937; | 2×GOL; | ||||
Assess | ||||||
X-ray crystal structure of Cyclophilin A/HIV-1 CA N-terminal domain (1-146) O-type chimera Complex. |
Heteromer P12497; P62937; | |||||
Assess | ||||||
X-ray crystal structure of Cyclophilin A/HIV-1 CA N-terminal domain (1-146) M-type H87A,G89A Comple… |
Heteromer P62937; Q72497; | |||||
Assess | ||||||
X-ray crystal structure of Cyclophilin A/HIV-1 CA N-terminal domain (1-146) M-type Complex. |
Heteromer P62937; Q72497; | |||||
Assess | ||||||
HUMAN CYCLOPHILIN A BOUND TO THE AMINO-TERMINAL DOMAIN OF HIV-1 CAPSID |
Heteromer P12497; P62937; | |||||
Assess | ||||||
Crystal structure of calcineurin-cyclophilin-cyclosporin shows common but distinct recognition of i… |
Heteromer P62937; P63098; Q08209; | 2×ZN; 2×FE; 8×CA; | ||||
Assess | ||||||
CA-targeting nanobody is a tool for studying HIV-1 capsid lattice interactions |
Heteromer B6DRA0; P62937; | |||||
Assess | ||||||
Cyclophilin a complexed with a fragment of crk-ii |
Heteromer P46108; P62937; | |||||
Assess | ||||||
Tricomplex of RMC-7977, HRAS WT, and CypA |
Heteromer P01112; P62937; | 1×GNP; 1×MG; 1×ZNI; | ||||
Assess | ||||||
Structure of the alpha-Synuclein PreNAC/Cyclophilin A-complex |
Heteromer P37840; P62937; | |||||
Assess | ||||||
Tricomplex of Compound-1, KRAS G12C, and CypA |
Heteromer P01116; P62937; | 1×GNP; 1×MG; 1×YV6; | ||||
Assess | ||||||
Tricomplex of RMC-7977, KRAS WT, and CypA |
Heteromer P01116; P62937; | 1×GNP; 1×MG; 1×ZNI; | ||||
Assess | ||||||
Tricomplex of RMC-6236, KRAS G12D, and CypA |
Heteromer P01116; P62937; | 1×GNP; 1×MG; 1×A1AHB; | ||||
Assess | ||||||
X-ray crystal structure of Cyclophilin A/HIV-1 CA N-terminal domain (1-146) M-type H87A Complex. |
Heteromer P62937; Q72497; | |||||
Assess | ||||||
acetyl-CypA:HIV-1 N-term capsid domain complex |
Heteromer P12497; P62937; | |||||
Assess | ||||||
TRIMCyp cyclophilin domain from Macaca mulatta: H70C mutant, HIV-1 CA(O-loop) complex |
Heteromer P12497; P62940; | |||||
Assess | ||||||
Crystal Structure of human calcineurin complexed with cyclosporin A and human cyclophilin |
Heteromer P62937; P63098; Q08209; | 1×PO4; 4×CA; | ||||
Assess | ||||||
Structure of the native full-length HIV-1 capsid protein in complex with Cyclophilin A from helical… |
Heteromer P04591; P62937; | |||||
Assess | ||||||
Structure of the native full-length HIV-1 capsid protein in complex with Cyclophilin A from helical… |
Heteromer P04591; P62937; | |||||
Assess | ||||||
Structure of the native full-length HIV-1 capsid protein in complex with Cyclophilin A from helical… |
Heteromer P04591; P62937; | |||||
Assess | ||||||
Structure of the native full-length HIV-1 capsid protein in complex with Cyclophilin A from helical… |
Heteromer P04591; P62937; | |||||
Assess | ||||||
Structure of the native full-length HIV-1 capsid protein in complex with Cyclophilin A from helical… |
Heteromer P04591; P62937; | |||||
Assess | ||||||
Structure of the native full-length HIV-1 capsid protein in complex with Cyclophilin A from helical… |
Heteromer P04591; P62937; | |||||
Assess | ||||||
Cyclophilin A Stabilize HIV-1 Capsid through a Novel Non- canonical Binding Site |
Heteromer P04591; P62937; | |||||
Assess | ||||||
Tricomplex of RMC-7977, KRAS G12A, and CypA |
Heteromer P01116; P62937; | 1×GNP; 1×MG; 1×ZNI; | ||||
Assess | ||||||
Tricomplex of RMC-7977, KRAS G12R, and CypA |
Heteromer P01116; P62937; | 1×GNP; 1×MG; 1×ZNI; | ||||
Assess | ||||||
Tricomplex of RMC-7977, KRAS G12V, and CypA |
Heteromer P01116; P62937; | 1×GNP; 1×MG; 1×ZNI; | ||||
Assess | ||||||
TRIMCyp cyclophilin domain from Macaca mulatta: HIV-2 CA cyclophilin-binding loop complex |
Heteromer P04590; P62940; | |||||
Assess | ||||||
Tricomplex of RMC-7977, KRAS G12D, and CypA |
Heteromer P01116; P62937; | 1×GNP; 1×MG; 1×ZNI; | ||||
Assess | ||||||
TRIMCyp cyclophilin domain from Macaca mulatta: HIV-1 CA(O-loop) complex |
Heteromer P12497; P62940; | |||||
Assess | ||||||
Maedi visna virus Vif in complex with CypA and E3 ubiquitin ligase |
Heteromer P62937; P69717; Q15369; Q15370; | 2×ZN; | ||||
Assess | ||||||
Tricomplex of RMC-7977, KRAS G12S, and CypA |
Heteromer P01116; P62937; | 1×GNP; 1×MG; 1×ZNI; | ||||
Assess | ||||||
Crystal structures of cyclophilin A complexed with cyclosporin A and N-methyl-4-[(E)-2-butenyl]-4,4… | homo-10-mer | |||||
Assess | ||||||
Crystal structures of cyclophilin A complexed with cyclosporin A and N-methyl-4-[(E)-2-butenyl]-4,4… | homo-10-mer | |||||
Assess | ||||||
acetyl-CypA:cyclosporine complex | homo-10-mer | |||||
Assess | ||||||
Free acetyl-CypA trigonal form | homo-2-mer | 1×GOL; 2×SO4; | ||||
Assess | ||||||
X-ray structure of CypA-C52AK125C/CsA/aromatic foldamer complex | homo-2-mer | 2×7I7; 4×QUK; 2×QVS; 2×QUJ; 2×7IB; | ||||
Assess | ||||||
RECOMBINANT CYCLOPHILIN A FROM HUMAN T CELL | homo-2-mer | |||||
Assess | ||||||
Structure of Cyclophilin A in complex with GlyPro. | monomer | 1×GLY; 1×PRO; | ||||
Assess | ||||||
Cyclophilin A single mutant D66A in complex with an inhibitor. | monomer | 1×EA4; 1×DMS; | ||||
Assess | ||||||
Cyclophilin A complexed with tri-vector ligand 10. | monomer | 1×F1Q; | ||||
Assess | ||||||
Structure of Cyclophilin A in complex with 2,3-Diaminopyridine | monomer | 1×76X; | ||||
Assess | ||||||
Cyclophilin A complexed with tri-vector ligand 5. | monomer | 1×F1Z; | ||||
Assess | ||||||
Structure of cyclophilin A in complex with hexahydropyrimidin-2-one | monomer | 3×L60; 1×TRS; | ||||
Assess | ||||||
Structure of cyclophilin A in complex with 3-amino-1H-pyridin-2-one | monomer | 1×92Z; | ||||
Assess | ||||||
Cyclophilin A complexed with tri-vector ligand 4. | monomer | 1×L36; | ||||
Assess | ||||||
Cyclophilin A complexed with tri-vector ligand 2. | monomer | 1×L36; | ||||
Assess | ||||||
TRIMCyp cyclophilin domain from Macaca mulatta: H70C mutant | monomer | 1×GOL; | ||||
Assess | ||||||
Structure of cyclophilin A in complex with 3,4-diaminobenzamide | monomer | 1×93K; | ||||
Assess | ||||||
CypA Mutant - I97V S99T C115S | monomer | |||||
Assess | ||||||
Structure of cyclophilin A in complex with 4-chloropyrimidin-5-amine | monomer | 2×938; | ||||
Assess | ||||||
Structure of Cyclophilin A in complex with benzohydrazide. | monomer | 2×WM4; | ||||
Assess | ||||||
Multiconformer synchrotron model of CypA at 100 K | monomer | |||||
Assess | ||||||
Structure of cyclophilin A in complex with pyridine-3,4-diamine | monomer | 1×L89; | ||||
Assess | ||||||
Structure of cyclophilin A in complex with 2-chloropyridin-3-amine | monomer | 1×L97; | ||||
Assess | ||||||
Human cyclophilin A bound to a series of acylcic and macrocyclic inhibitors: tert-butyl [(2S)-1-{[(… | monomer | 1×UMM; | ||||
Assess | ||||||
Structure of Cyclophilin A in complex with Benzamide. | monomer | 1×UNU; | ||||
Assess | ||||||
Human cyclophilin A bound to a series of acylcic and macrocyclic inhibitors: (2R,5S,11S,14S,18E)-2,… | monomer | 1×UOG; | ||||
Assess | ||||||
Cyclophilin A complexed with the tri-vector ligand 8. | monomer | 1×F1E; 1×GOL; | ||||
Assess | ||||||
Structure of cyclophilin A in complex with 3-chloropyridin-2-amine | monomer | 2×93E; | ||||
Assess | ||||||
Structure of cyclophilin A in complex with 3,4-diaminobenzohydrazide | monomer | 1×L99; | ||||
Assess | ||||||
Structure of Cyclophilin A in complex with cyclohexanecarboxamide. | monomer | 1×WM2; | ||||
Assess | ||||||
Enzymatic and Structural Characterisation of Non Peptide Ligand Cyclophilin Complexes | monomer | 1×E1P; | ||||
Assess | ||||||
Cyclophilin A complexed with tri-vector ligand 9. | monomer | 1×F0W; | ||||
Assess | ||||||
Cyclophilin A complexed with tri-vector ligand 15. | monomer | 1×F0Q; 2×FMT; 1×GOL; | ||||
Assess | ||||||
Enzymatic and structural characterization of non peptide ligand cyclophilin complexes | monomer | |||||
Assess | ||||||
Structure of Cyclophilin A in complex with Saccharin. | monomer | 5×LSA; | ||||
Assess | ||||||
THE ROLE OF WATER MOLECULES IN THE STRUCTURE-BASED DESIGN OF (5-HYDROXYNORVALINE)-2-CYCLOSPORIN: SY… | monomer | |||||
Assess | ||||||
HUMAN CYCLOPHILIN A COMPLEXED WITH 2-THR CYCLOSPORIN | monomer | |||||
Assess | ||||||
Enzymatic and structural characterization of non peptide ligand cyclophilin complexes | monomer | 1×1P3; | ||||
Assess | ||||||
Structure of cyclophilin A in complex with 3-methylpyridin-2-amine | monomer | 2×93Q; | ||||
Assess | ||||||
Structure of Cyclophilin A in complex with benzenesulfonohydrazide. | monomer | 1×WM3; | ||||
Assess | ||||||
HUMAN CYCLOPHILIN A COMPLEXED WITH 4 4-HYDROXY-MELEU CYCLOSPORIN | monomer | |||||
Assess | ||||||
HUMAN CYCLOPHILIN A COMPLEXED WITH 2-VAL 3-S-METHYL-SARCOSINE CYCLOSPORIN | monomer | |||||
Assess | ||||||
HUMAN CYCLOPHILIN A COMPLEXED WITH 1-(6,7-DIHYDRO)MEBMT 2-VAL 3-D-(2-S-METHYL)SARCOSINE CYCLOSPORIN | monomer | |||||
Assess | ||||||
IMPROVED BINDING AFFINITY FOR CYCLOPHILIN A BY A CYCLOSPORIN DERIVATIVE SINGLY MODIFIED AT ITS EFFE… | monomer | |||||
Assess | ||||||
HUMAN CYCLOPHILIN A COMPLEXED WITH THR2, LEU5, D-HIV8, LEU10 CYCLOSPORIN | monomer | |||||
Assess | ||||||
HUMAN CYCLOPHILIN A COMPLEXED WITH 2-VAL CYCLOSPORIN | monomer | |||||
Assess | ||||||
HUMAN CYCLOPHILIN A COMPLEXED WITH 3-D-SER CYCLOSPORIN | monomer | |||||
Assess | ||||||
Structure of Cyclophilin A in complex with Picolinamide. | monomer | 3×WM1; | ||||
Assess | ||||||
HUMAN CYCLOPHILIN A COMPLEXED WITH 2-VAL 3-(N-METHYL)-D-ALANINE CYCLOSPORIN | monomer | |||||
Assess | ||||||
Cyclophilin A complexed with tri-vector ligand 7. | monomer | 1×F0T; | ||||
Assess | ||||||
Structure of cyclophilin A in complex with hexahydropyrimidine-2-thione | monomer | 1×93B; | ||||
Assess | ||||||
HUMAN CYCLOPHILIN A COMPLEXED WITH 4 MEILE CYCLOSPORIN | monomer | |||||
Assess | ||||||
Structure of PPIA in complex with FP29102, a Helicon Polypeptide | monomer | 1×NH2; 1×WHL; | ||||
Assess | ||||||
X-RAY STRUCTURE OF A MONOMERIC CYCLOPHILIN A-CYCLOSPORIN A CRYSTAL COMPLEX AT 2.1 ANGSTROMS RESOLUT… | monomer | |||||
Assess | ||||||
The Sanglifehrin-Cyclophilin Interaction: Degradation Work, Synthetic Macrocyclic Analogues, X-ray … | monomer | 1×SFM; | ||||
Assess | ||||||
THE X-RAY STRUCTURE OF (MEBM2T)1-CYCLOSPORIN COMPLEXED WITH CYCLOPHILIN A PROVIDES AN EXPLANATION F… | monomer | |||||
Assess | ||||||
Crystal structure of cyclophilin A in complex with Voclosporin E-ISA247 | monomer | |||||
Assess | ||||||
Crystal structure of cyclophilin A in complex with Voclosporin Z-ISA247 | monomer | |||||
Assess | ||||||
Cyrstal Structure of Human Cyclophilin-A in Complex with suc-AGPF-pNA | monomer | |||||
Assess | ||||||
Extending the eNOE data set of large proteins by evaluation of NOEs with unresolved diagonals | monomer | |||||
Assess | ||||||
DETERMINATION OF THE NMR SOLUTION STRUCTURE OF THE CYCLOPHILIN A-CYCLOSPORIN A COMPLEX | monomer | |||||
Assess | ||||||
Structural ensemble of the enzyme cyclophilin reveals an orchestrated mode of action at atomic reso… | monomer | |||||
Assess | ||||||
NMR structure of crosslinked cyclophilin A | monomer | |||||
Assess | ||||||
HUMAN CYCLOPHILIN A, UNLIGATED, NMR, 20 STRUCTURES | monomer | |||||
Assess | ||||||
High-resolution isotropic multiconformer synchrotron model of CypA at 273 K | monomer | |||||
Assess | ||||||
Cryogenic structure of CypA | monomer | |||||
Assess | ||||||
Multiconformer synchrotron model of CypA at 150 K | monomer | |||||
Assess | ||||||
Structure of PPIA in complex with FP29103, a Helicon Polypeptide | monomer | 1×WHL; | ||||
Assess | ||||||
Multiconformer synchrotron model of CypA at 180 K | monomer | |||||
Assess | ||||||
Human cyclophilin A bound to a series of acylcic and macrocyclic inhibitors | monomer | 1×UMM; | ||||
Assess | ||||||
Discovery of a Potent Cyclophilin Inhibitor (Compound 8) based on Structural Simplification of Sang… | monomer | 1×838; 1×SO4; | ||||
Assess | ||||||
CypA Mutant - S99T C115S | monomer | |||||
Assess | ||||||
X-Ray structure of a CypA-Alisporivir complex at 1.5 angstrom resolution | monomer | 1×CL; | ||||
Assess | ||||||
Structure of the N-terminal capsid domain of HIV-2 | monomer | |||||
Assess | ||||||
Human cyclophilin A bound to a series of acylcic and macrocyclic inhibitors: (2R,5S,11S,14S,18E)-2,… | monomer | 1×UOD; | ||||
Assess | ||||||
Room temperature structure of CypA mutant Ser99Thr | monomer | |||||
Assess | ||||||
CYPA COMPLEXED WITH HAGPIA (PSEUDO-SYMMETRIC MONOMER) | monomer | |||||
Assess | ||||||
CYPA COMPLEXED WITH HAGPIA | monomer | |||||
Assess | ||||||
Human Cyclophilin A double mutant C52AK125C | monomer | 2×GOL; | ||||
Assess | ||||||
Structure of human cyclophilin A in complex with the novel immunosuppressant sanglifehrin A at 1.6A… | monomer | 1×SFA; | ||||
Assess | ||||||
SIMILARITIES AND DIFFERENCES BETWEEN HUMAN CYCLOPHILIN A AND OTHER BETA-BARREL STRUCTURES. STRUCTUR… | monomer | |||||
Assess | ||||||
CYCLOPHILIN A COMPLEXED WITH DIPEPTIDE ALA-PRO | monomer | 1×ALA; 1×PRO; | ||||
Assess | ||||||
SmBz bound to Cyclophilin A | monomer | 2×CL; | ||||
Assess | ||||||
Human cyclophilin A at 278K, Data set 2 | monomer | |||||
Assess | ||||||
Human cyclophilin A at 100K, Data set 9 | monomer | |||||
Assess | ||||||
Human cyclophilin A at 278K, Data set 4 | monomer | |||||
Assess | ||||||
Human cyclophilin A at 100K, Data set 6 | monomer | |||||
Assess | ||||||
Human cyclophilin A at 100K, Data set 7 | monomer | |||||
Assess | ||||||
Human cyclophilin A at 100K, Data set 8 | monomer | |||||
Assess | ||||||
Human cyclophilin A at 278K, Data set 5 | monomer | |||||
Assess | ||||||
Human cyclophilin A at 100K, Data set 4 | monomer | |||||
Assess | ||||||
Human cyclophilin A at 278K, Data set 1 | monomer | |||||
Assess | ||||||
Human cyclophilin A at 278K, Data set 6 | monomer | |||||
Assess | ||||||
Human cyclophilin A at 100K, Data set 5 | monomer | |||||
Assess | ||||||
Human cyclophilin A at 278K, Data set 7 | monomer | |||||
Assess | ||||||
Human cyclophilin A at 100K, Data set 2 | monomer | |||||
Assess | ||||||
Human cyclophilin A at 278K, Data set 8 | monomer | |||||
Assess | ||||||
Human cyclophilin A at 100K, Data set 1 | monomer | |||||
Assess | ||||||
Human cyclophilin A at 100K, Data set 3 | monomer | |||||
Assess | ||||||
Human cyclophilin A at 278K, Data set 9 | monomer | |||||
Assess | ||||||
Human cyclophilin A at 278K, Data set 3 | monomer | |||||
Assess | ||||||
Multiconformer fixed-target X-ray free electron (XFEL) model of CypA at 273 K | monomer | |||||
Assess | ||||||
Human cyclophilin A bound to a series of acylcic and macrocyclic inhibitors: (2R,5S,11S,14S,18E)-14… | monomer | 1×UOJ; | ||||
Assess | ||||||
Structure of PPIA in complex with the peptide of NRF2 | monomer | |||||
Assess | ||||||
crystal structure of human CypA mutant K131A | monomer | 1×MG; | ||||
Assess | ||||||
CYCLOPHILIN A COMPLEXED WITH DIPEPTIDE SER-PRO | monomer | 1×SER; 1×PRO; | ||||
Assess | ||||||
STRUCTURE OF CYCLOPHILIN COMPLEXED WITH (D)ALA CONTAINING TETRAPEPTIDE | monomer | |||||
Assess | ||||||
Discovery of a Potent Cyclophilin Inhibitor (Compound 5) based on Structural Simplification of Sang… | monomer | 1×78E; | ||||
Assess | ||||||
CYCLOPHILIN A COMPLEXED WITH DIPEPTIDE GLY-PRO | monomer | 1×GLY; 1×PRO; | ||||
Assess | ||||||
CYCLOPHILIN A COMPLEXED WITH DIPEPTIDE HIS-PRO | monomer | 1×HIS; 1×PRO; | ||||
Assess | ||||||
Human Cyclophilin A Complexed with an Inhibitor | monomer | 1×EA4; | ||||
Assess | ||||||
Structure of cyclophilin complexed with sulfur-substituted tetrapeptide AAPF | monomer | |||||
Assess | ||||||
Cryogenic structure of CypA mutant Ser99Thr (2) | monomer | |||||
Assess | ||||||
CYPA COMPLEXED WITH HVGPIA (PSEUDO-SYMMETRIC MONOMER) | monomer | |||||
Assess | ||||||
CYPA COMPLEXED WITH HVGPIA | monomer | |||||
Assess | ||||||
Cryogenic structure of CypA mutant Arg55Lys | monomer | |||||
Assess | ||||||
SECYPA COMPLEXED WITH HAGPIA (PSEUDO-SYMMETRIC MONOMER) | monomer | |||||
Assess | ||||||
SECYPA COMPLEXED WITH HAGPIA | monomer | |||||
Assess | ||||||
High-resolution multiconformer synchrotron model of CypA at 273 K | monomer | |||||
Assess | ||||||
Free acetyl-CypA orthorhombic form | monomer | |||||
Assess | ||||||
Structure of PPIA in complex with PR dipeptide repeat | monomer | |||||
Assess | ||||||
Room temperature structure of CypA | monomer | |||||
Assess | ||||||
Discovery of a Potent Cyclophilin Inhibitor (Compound 6) based on Structural Simplification of Sang… | monomer | 1×78R; | ||||
Assess | ||||||
Multiconformer synchrotron model of CypA at 280 K | monomer | |||||
Assess | ||||||
Multiconformer synchrotron model of CypA at 240 K | monomer | |||||
Assess | ||||||
Multiconformer synchrotron model of CypA at 260 K | monomer | |||||
Assess | ||||||
Discovery of a Potent Cyclophilin Inhibitor (Compound 7) based on Structural Simplification of Sang… | monomer | 1×78X; | ||||
Assess | ||||||
Human cyclophilin A bound to a series of acylcic and macrocyclic inhibitors: (2R,5S,11S,14S,18E)-2,… | monomer | 1×UO7; | ||||
Assess | ||||||
Multiconformer synchrotron model of CypA at 300 K | monomer | |||||
Assess | ||||||
RT XFEL structure of CypA solved using celloluse carrier media | monomer | |||||
Assess | ||||||
Multiconformer synchrotron model of CypA at 310 K | monomer | |||||
Assess | ||||||
RT XFEL structure of CypA solved using MESH injection system | monomer | |||||
Assess | ||||||
RT XFEL structure of CypA solved using LCP injection system | monomer | |||||
Assess | ||||||
Human cyclophilin A bound to a series of acylcic and macrocyclic inhibitors | monomer | 1×ZXX; | ||||
Assess | ||||||
Discovery of a Potent Cyclophilin Inhibitor (Compound 3) based on Structural Simplification of Sang… | monomer | 1×7HG; | ||||
Assess | ||||||
TRIMCyp cyclophilin domain from Macaca mulatta: cyclosporin A complex | monomer | |||||
Assess | ||||||
MicroED structure of a FIB-milled CypA Crystal | monomer | |||||
Assess | ||||||
Cryogenic structure of CypA mutant Ser99Thr | monomer | |||||
Assess |
1 SWISS-MODEL model
Template | Oligo-state | QMEANDisCo | Range | Ligands | Trg-Tpl Seq id (%) | |
---|---|---|---|---|---|---|
1mik.1.A | monomer | 0.90 | 100.00 | |||
Assess |